ONION D, ARGENT RH, REECE-SMITH AM, CRAZE ML, PINEDA RG, CLARKE PA, RATAN HL, PARSONS SL, LOBO DN, DUFFY JP, ATHERTON JC, MCKENZIE AJ, KUMARI R, KING P, HALL BM and GRABOWSKA AM, 2016. 3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors. Molecular cancer therapeutics. 15(4), 753-63 SAUNDERS JH, ONION D, COLLIER P, DORRINGTON MS, ARGENT RH, CLARKE PA, REECE-SMITH AM, PARSONS SL and GRABOWSKA AM, 2016. Individual patient oesophageal cancer 3D models for tailored treatment. Oncotarget.
HEROD MR, PINEDA RG, MAUTNER V and ONION D, 2014. Quantum Dot Labelling of Adenovirus Allows Highly Sensitive Single Cell Flow and Imaging Cytometry. Small (Weinheim an der Bergstrasse, Germany).
CHAKUPURAKAL G, ONION D, BONNEY S, COBBOLD M, MAUTNER V and MOSS P, 2013. HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy. Journal of immunotherapy (Hagerstown, Md. : 1997). 36(8), 423-31 DEACON, K., ONION, D., KUMARI, R., WATSON, S.A. and KNOX, A.J., 2012. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer Journal of Biological Chemistry. 287(47), 39967-39981
CHAKUPURAKAL, GEOTHY, ONION, DAVID, COBBOLD, MARK, MAUTNER, VIVIEN and MOSS, PAUL A H, 2010. Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin alpha4beta7. AIDS (London, England). 24(2), 205-10
ONION, DAVID, PATEL, PRASHANT, PINEDA, ROBERT G, JAMES, NICHOLAS and MAUTNER, VIVIEN, 2009. Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer. Human gene therapy. 20(11), 1249-58 BRUTON, R K, RASTI, M, MAPP, K L, YOUNG, N, CARTER, R Z, ABRAMOWICZ, I A, SEDGWICK, G G, ONION, D F, SHUEN, M, MYMRYK, J S, TURNELL, A S and GRAND, R J A, 2007. C-terminal-binding protein interacting protein binds directly to adenovirus early region 1A through its N-terminal region and conserved region 3. Oncogene. 26(53), 7467-79
ONION, DAVID, CROMPTON, LAURA J, MILLIGAN, DONALD W, MOSS, PAUL A H, LEE, STEVEN P and MAUTNER, VIVIEN, 2007. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. The Journal of general virology. 88(Pt 9), 2417-25
LYONS, MARK, ONION, DAVID, GREEN, NICKY K, ASLAN, KRISS, RAJARATNAM, RATNA, BAZAN-PEREGRINO, MIRIAM, PHIPPS, SUE, HALE, SARAH, MAUTNER, VIVIEN, SEYMOUR, LEONARD W and FISHER, KERRY D, 2006. Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Molecular therapy : the journal of the American Society of Gene Therapy. 14(1), 118-28
YOUNG, LAWRENCE S, SEARLE, PETER F, ONION, DAVID and MAUTNER, VIVIEN, 2006. Viral gene therapy strategies: from basic science to clinical application. The Journal of pathology. 208(2), 299-318
SEYMOUR, L W, FISHER, K D, GREEN, N K, HALE, S J, LYONS, M, MAUTNER, V, NICUM, S, ONION, D, OUPICKY, D, STEVENSON, M and ULBRICH, K, 2003. Adenovirus retargeting and systemic delivery. Ernst Schering Research Foundation workshop. 107-14
RIVETT, A JENNIFER, BOSE, SUCHIRA, PEMBERTON, ALEXANDER J, BROOKS, PAUL, ONION, DAVID, SHIRLEY, DAVID, STRATFORD, FIONA L L and FORTI, KATIA, Assays of proteasome activity in relation to aging. Experimental gerontology. 37(10-11), 1217-22